Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2026 Mar 22;34(6):3701. doi: 10.1016/j.ymthe.2026.03.001

AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage

Apolonia Gardner, Shuai Wang, Adam Daniels, Dan Li, Christine Wu, Lucas Lin, Christin Hong, Sophia R Zhao, Richard T Born, Kamil Kruczek, Genevieve Weist, Laura Barrio Real, Joan Wicks, Mohamad Nayal, Ashley Carter, Christine Ott, Virginia Haurigot, Constance L Cepko ∗
PMCID: PMC13239674  PMID: 41871575

Main text

(Molecular Therapy 34, 3245–3269; June 2026)

In the originally published version of this article, the author list mistakenly appeared out of order; specifically, Richard T. Born appeared later in the author list than intended. The corrected author list appears here and has been revised in the published article. The authors regret this error.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES